Education
About Us
Working with TipRanks
Follow Us
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 654.00K | $ 1.66M | $ 518.48K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 654.00K | $ 1.66M | $ 518.48K |
| Operating Income | $ -105.77M | $ -68.51M | $ -60.51M | $ -50.64M | $ -4.59M |
| EBITDA | $ -96.19M | $ -64.35M | $ -58.04M | $ -50.61M | $ -4.59M |
| Net Income | $ -98.33M | $ -66.39M | $ -59.28M | $ -50.62M | $ -5.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 121.52M | $ 121.47M | $ 77.33M | $ 135.86M | $ 29.37M |
| Total Assets | $ 146.94M | $ 139.81M | $ 97.08M | $ 136.86M | $ 29.41M |
| Total Debt | $ 9.92M | $ 11.64M | $ 13.48M | $ 0.00 | $ 0.00 |
| Net Debt | $ -25.09M | $ -109.83M | $ -63.85M | $ -135.86M | $ -29.37M |
| Total Liabilities | $ 30.10M | $ 26.27M | $ 210.03M | $ 192.46M | $ 34.95M |
| Stockholders' Equity | $ 116.84M | $ 113.53M | $ -112.95M | $ -55.60M | $ -5.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -81.63M | $ -59.66M | $ -55.46M | $ -44.37M | $ -3.13M |
| Operating Cash Flow | $ -81.15M | $ -59.50M | $ -54.56M | $ -44.18M | $ -3.13M |
| Investing Cash Flow | $ -94.08M | $ -165.00K | $ -901.00K | $ -188.00K | $ 0.00 |
| Financing Cash Flow | $ 88.78M | $ 103.79M | $ 189.00K | $ 150.86M | $ 32.38M |